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INTRODUCTION
Transaminases are intracellular enzymes and may be present in
blood from normal individuals. Quantitative determinations of
these enzymes have been used extensively as a laboratory test in
human medicine to detect cellular destruction. This laboratory
procedure has recently attained increased utilization in veter-
inary medicine with the development of kits of prepared reagents.
Normal serum transaminases have been reported in the dog but very
few reports have been made on the significance of these enzymes
in urine and cerebrospinal fluid In this speoies. Most of the
transminases normals reported have been a result of one test from
each of several individuals.
One purpose of this research was to establish normal oxal-
acetic and pyruvic transaminases in blood, urine, and cerebro-
spinal fluid of the dog using commercially produced reagents. No
literature was found reporting the use of the transaminases in
canine distemper or nephritis of the dog. Other purposes were to
evaluate these enzymatic tests in dogs with natural infeotion of
canine distemper and associated central nervous symptoms, and
artificially produced nephritis.
Establishment of the normal is important In order to study
the abnormal. Canine distemper and central nervous symptoms are
often observed in dogs. Nephritis is also a common disease of
dogs. Therefore, it is important for the veterinary clinician and
the research worker to know the value of these enzymatic tests
associated with these diseases.
RRVIFW OP LITERATURE
Chemistry of Reaction
The transfer of an amine group from an amino acid to an
a-ketonic acid to form a different amino acid is one of the means
of synthesizing amino acids in the intermediate metabolism of
animals and plants. This process is called transamination, and
the enzymes that catalyze this reaction are called transaminases
(Gurtler and Richter, 1959).
Braunstein and Kritzmann (1937), as reported by Green et al.
(1945), discovered the process of transamination in animals and
plants. These same authors (1937), as reported by Gurtler and
Richter (1959), indicated that this process needed the presenoe
of a dicarboxylic acid as a donor or acceptor of the amino group.
Sohlenk and Snell (1945), as reported by Gurtler and Richter
(1959), hypothesized that pyridoxal phosphate functions as a co-
enzyme for this reaction. O'Kane and Gunsalis (1947), as reported
by Karmen et al. (1955), confirmed that pyridoxal phosphate acted
as the coenzyme in the transaminase system.
Cohen and Hekhuis (1941) believed that there were three sep-
arate reactions in the transamination in tissues:
Reaction (1) Glutamic acid + oxalacetic acid==a-ketoglutaric
acid + aspartic acid
Reaction (2) Glutamic acid + pyruvic acid^r^a-ketoglutaric
acid + alanine
Reaction (3) Aspartic acid + pyruvic acid^ztoxalacetic
acid + alanine.
They felt that analytical determination of reaction (3) would not
be reliable. Most of the enzymatic determinations that have been
utilized are the glutamic oxalacetic transaminase (GOT) of reac-
tion (1) and the glutamic pyruvic transaminase (GPT) of reaction
(2).
Fnzyme Specificity
Cohen and Hekhuis (1941) indicated that the rate of reaction
of glutamic, oxalacetic, and pyruvic acids was very slow with
other amino acids. The authors believed these amino acids were
not very important in intermediary metabolism. The GOT enzyme
was reported to be highly specific by Green et al. (1945) and they
noted that no other amino acid was found to be as active as a
donor to a-ketoglutaric acid as glutamic acid. These workers
found that the following chemicals could not replace aspartic
acid: alanine, leucine, serine, and methionine. They also re-
ported that glutamine, pyrrol idinecarboxylic acid could not re-
place glutamic acid. Mesoxalic acid could replace oxalacetic acid
when both were present. Green et al, (1945) also found the
glutamic alanine of pig heart to be quite stable. In the reaotion
between alanine and a-ketoglutarlc acid, aminobutyric acid would
react but at slower speed. Some chemicals that would not react
were N-methylalanine, phenylalanine, valine, serine, methionine,
leucine, a-aminovaleric acid, cysteic acid, and a-alanine.
A-ketobutyric acid and mesoxalic acid could replace the pyruvic
acid in the reaction between glutamic acid and pyruvic acid. In
this reaction glutamio acid could not be replaced by cysteic acid,
glycylcysteine, glutathione, pyrrolldonecarboxylic acid, acetyl-
glutamic acid, leucine, methionine, glutamine, tyrosine, threonine,
a-aminocaproic aoid, lysine, phenylalanine, cystine, valine, and
hydroxyprollne
.
It was reported by Cammarata and Cohen (1950) that 22 amino
acids in addition to alanine, aspartic acid, and glutamic acid
could participate in the transaminase reaction. Fach transamina-
tion appeared to be due to a different transaminase. These re-
actions were accelerated by pyridoxal phosphate and Inhibited
slightly by ammonia.
Beaton et al. (1957) concluded that liver alanine-glutamic
transaminase activity was related to the direction of orotein
metabolism. In the study of kwashiorkor and serum transaminase.
Baron (1960) found GOT increased in undernourished adults, but the
GPT increase was slight. This author postulated that there were
two opposing factors that could affeot serum enzyme levels in pro-
tein deficiency: (1) deficient protein intake could affeot the
synthesis of serum enzymes since enzymes are protein, and (2)
tissue wasting and cellular destruction could result in an in-
creased level of serum enzymes. It was also reported that normal
Europeans probably have higher enzyme values than normal Nigerians.
Berezowskaya and Smirnova (1956) studied rats fed 3 per cent
protein diet and found a decrease in transamination of pyruvic and
oxalacetio add as compared to normal rats. This alteration could
be seen after four or five days on the low protein diet. The
velocity of transamination between alanine and ketoglutarlc acid
was reduced by 30 per cent and the velocity decreased 25 per cent
between asparagine and ketoglutaric acid as compared to normal
rats.
Stability
Green et al. (1945) stated that pig heart frozen in dry ice
maintained transaminase activity indefinitely. LaDue et al.
(1954) found that serum stored in the refrigerator one to ten
days was satisfactory for transaminase determination. Karmen
et al. (1955) stored serum samples 10 minutes to 96 hours at room
temperature and for one to two weeks under refrigeration of to
5° C without observing any change in transaminase activity. The
same workers reported that freezing or lyophilizing serum did not
cause any alteration in the enzyme activity. They also reported
that no enzymatic alteration occurred in serum subjected to a
temperature of 56° C for 25 minutes. However, in serum heated to
100° C for 10 minutes there was a 10 per cent decrease in enzyme
activity. Steinberg et al. (1956) reported little or no decrease
in enzyme aotivity after serum had been stored in the refrigerator
three weeks, and that serum stored at 4° C for four months con-
tained 60 per oent of its original enzyme activity. Steinberg
and Ostrow (1955) found that serum could be stored in the re-
frigerator for three weeks without a decrease in its enzyme
activity. Gurtler and Richter (1959) stored serum at to 5° C
for two weeks without significant loss of activity. They also
noted that storage of serum up to four days at room temperature
did not influence enzymatic activity.
6In contrast, Dubaoh (1957), as reported by Gurtler and
Richter (1959), found a considerable decrease in activity after
one-day storage of serum below room temperature. This same author
reported a temperature of 18° C caused a serum glutamic oxalacetic
transaminase (SGOT) decrease from 134 to 70 units after 21 hours.
After incubation at 58° C, Gurtler and Richter (1959) observed a
decrease from 235 units to 200 units and from 120 units to 106
units. Chinsky et al. (1957), as reported by Gurtler and Richter
(1959), reported almost identical stabilities of GOT and GPT.
While this storage may or may not cause a decrease in enzyme ac-
tivity, it has been reported that a temperature rise from 25° C
to 37° C during determination of the enzyme will double the GOT
values (Bowers et al., 1958).
Comparison of Serum, Plasma, and Hemolyzed Blood GOT
Steinberg and Ostrow (1955) noted that hemolysis of human red
blood cells caused an approximate eightfold increase in GOT
activity. Steinberg et al. (1956) noted, while studying human
transaminases, that the presence of lysed red blood cells in the
serum resulted in greater GOT activity. These workers noted no
significant alteration of transaminase values of plasma from
heparinized or oxalated blood, and no significant changes were
found in serum collected at 9:30 a.m., 11:30 a.m., and 2:30 o.m.
Karmen et al. (1955) reported that human whole blood hemolysates
contained about ten times the amount of GOT as normal serum. They
noted no significant difference in transaminase levels of serum or
plasma from oxalated, citrated, or heparinized blood. Baron
(1960) reported that hemolysis caused very little alteration in
either GOT or GPT activity.
Gurtler and Richter (1959) studied the effect of hemolysis
on SGOT activity in 5 horses. Hemolyzed whole blood had approxi-
mately 50 per cent more SGOT activity than its corresponding
serum. These workers also noted that the GOT was slightly higher
in serum than in corresoonding plasma. Five corresponding sera,
plasma, and hemolyzed whole blood samples from cattle were
studied. The SGOT activity was slightly higher than the plasma
GOT activity. Hemolyzed whole blood contained about one-half as
much GOT as did the serum. Hemolyzed whole blood samples from
four pigs contained about ten times greater GOT activity than the
corresoonding serum. The plasma of one pig contained higher GOT
activity than that of the corresoonding serum, but the plasma
from two other pigs contained less GOT activity than the corre-
sponding serum. Gurtler and Richter (1959) studied a single
human sample and found SGOT to be 21 units, the plasma GOT 24
units, and the hemolyzed whole blood 127 units. Their work
pointed out the necessity of collecting blood serum or plasma in
a manner which would minimize hemolysis.
Methods of Determining Knzymatic Activity
Karmen et al. (1955) studied SGOT and serum glutamic pyruvic
transaminase (SGPT) using paper chromatography. This method was
sensitive, simple, and there was no loss of glutamate during the
incubation period. Paper chromatography was utilized for both
reactions and the results were reported in micro-moles of glutamate
8produced per milliliter of serum per hour at 37° C.
Karmen (1955) developed a method for determining GOT activity
of human serum by reducing the oxalacetate formed in the trans-
aminase reaction with diphosphopyridine nucleotide (DPNH). The
progress of this reaction was followed spectrophotometrically at
340 rau using a Beckman model DU spectrophotometer. The results
were reoorted in units per milliliter per hour, one unit being
the decrease in optical density of 0.001 at room temperature.
Wroblewski and LaDue (1956) used the same procedure as Karmen
(1955) for determining GPT activity in human serum.
Tonhazy et al. (1950) developed a colorimetric method of de-
termining glutamic aspartic transaminase in tissues.
Cabaud et al. (1956) measured GOT activity in serum of
patients by converting the oxalacetate to pyruvate using aniline
citrate. The pyruvate reacted with 2,4-dinitrophenyl hydrazine
and a strong alkali to form a hydrazone, the quantity of which was
determined colorimetrically at 490 mu with the blank set at 100
per cent transmittance . One unit equalled the formation of 1
gamma of pyruvate under conditions of the test. The same workers
checked 35 sera and found a 16 ner cent error. Wroblewski and
Cabaud (1957) described a similar procedure for determining
SGPT.
Steinberg et al. (1956) described a method for assaying SG0T
which was similar to that of Karmen's (1955). The change in
optical density was measured at 340 mu at 25° C. One unit equalled
a decrease in optical density of 0.001 per centimeter of light
path per minute of incubation at 25° C.
9Reitman and Frankel (1957) described a colorimetric method
for determining SGOT and SGPT which was a simplification of the
method of Cabaud et al. (1956). The incubation period for SGOT
was one hour at 40° C and for SGPT 30 minutes at 40° C. The
optical density was measured at 505 mu using water as the
reference standard. Any wavelength between 490 and 530 mu could
be used as long as it was keot constant. The readings were based
uoon the difference in absorption of a-ketoglutarate, oxal-
acetate, pyruvate, and 2,4-dinitrophenylhydrazone at 505 mu.
The ratio of pyruvate to a-ketoglutarate was related to trans-
aminase units. One unit was similar to one Karmen unit.
Bowers et al. (1958) described what was called a simole and
accurate method of determining SGOT and SGPT activity. The general
method of Karmen (1955) was used except the tests were incubated
at 37° C and read at 355 mu. These authors did not explain what
constituted a unit.
King (1958), as reported by Daly and Jordan (1959), used the
technique of Reitman and Frankel (1957) in which one unit equaled
the activity in 100 ml of serum which would convert one micro-mole
of amino acid to a keto acid in one hour at 37° C.
Serum Transaminase Levels in Normal Animals
A compilation of SGOT and SGPT values in normal animals is
shown in Table 1. In the dog, Lemley-Stone et al. (1955) reported
a normal mean SGOT level of 39 units with standard deviation of
3.5 units per milliliter. Nydlck et al. (1955) found the normal
SGOT range to be 8 to 40 units ner ml. Wakim et al. (1956) found
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a SGOT range of 0,70 to 1.34 uM/ml/hr. Cornelius et al. (1959)
reported the normal mean of canine SGOT to be 22.7 units and a
standard deviation of 5.4 units. The same author also found the
mean SGPT to be 21 #8 units and a standard deviation of 6.2 units.
Blinco and Dye (1958), working with lambs, reported a normal
SGOT range in one group of lambs of 97 to 191 units and in another
group found a normal SGOT range of 22 to 160 units. The normal
SGOT range in lambs of 19 to 99 units was reported by the same
authors. Kuttler and Marble (1958) also reported the normal SGOT
of calves and lambs. They found the mean SGOT levels of calves
from a so-called "disease free herd" to be 56 units with a stand-
ard deviation of 17 units. However, the mean SGOT level of normal
appearing calves from a known white muscle disease (WMD) affected
herd was 112 units with a standard deviation of 64 units. The
normal SGOT in a "disease free flock" of lambs was found to be
56 units with a standard deviation of 31 units. Normal appear-
ing lambs from a known WMD affected flock had a mean SGOT of 208
units with a standard deviation of 192 units.
Compagnucci (1959) found the normal SGOT range in the bovine
to be 48 to 83 units and the normal SGPT range was 9.2 to 20.4
units. The normal SGOT in 34 cattle studied by Gould and Grimes
(1959) was 38 to 102 Reitman-Prankel units with a mean of 64.9
units. Gurtler and Richter (1959) reported the normal range SGOT
in the ox to be 56 to 165 units while the SGPT was 9 to 64 units.
Cornelius et al. (1959) gave the normal mean SGOT of Holstein
cows as 55.8 ug pyruvate/ml and 43.8 Sigma-Frankel units. In
calves, the same workers found a normal mean SGOT of 25 ug
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pyruvate/ml and 23.6 Sigma-Frankel units. The normal mean SGPT
in cows was 16.2 ug pyruvate/ml and 19.7 Sigma-Frankel units.
Th8 calves' normal mean SOPT was recorded as being 2 ug pyruvate/ml
and 7.8 Sigma-Frankel units.
Cornelius et al. (1959) reported the normal mean SGOT of
pigs to be 31.1 Sigma-Frankel units while the SGPT was 27.3
Sigma-Frankel units. The standard deviations were 14.1 units and
7.8 units, respectively. Gurtler and Richter (1959) found the
normal SGOT range of pigs to be 10 to 98 units with a mean of 51
units and a standard deviation of 24.9 units. They also reported
the normal SGPT range of pigs to be 17 to 72 units and a mean of
47 with a standard deviation of 12 units
.
Gurtler and Richter (1959) reported the normal SGOT range in
horses to be 163 to 367 units with a mean of 260 units and a stand-
ard deviation of 42.8 units. The normal range of SGPT was to
20 units with a mean of 9 units and a standard deviation of 5.9
units. Cornelius et al. (1959) found the mean SGOT of the equine
to be 158 ug pyruvate/ml with a standard deviation of 37.4 ug
pyruvate/ml and 165 Sigma-Frankel units with a standard deviation
of 33.8 Sigma-Frankel units. The same workers reported the normal
mean SGPT of the equine of 8.0 ug pyruvate/ml with a standard
deviation of 5.9 ug pyruvate/ml and 11.0 Sigma-Frankel units with
a standard deviation of 3.8 Sigma-Frankel units.
Urine
Steinberg and Ostrow (1955) reported that normal human urine
contained less than 1 unit/ml of GOT. Dunn et al. (1958) found
14
no transaminase activity in the urine of dogs and postulated that
the enzyme molecule was too large to pass through the glomerulus
of the kidney or that the tubules were able to completely absorb
the enzyme. Chinskey et al. (1956) reported insignificant amounts
of transaminase activity in urine of normal humans. The same
workers found that patients with high SGOT had significant levels
of urine glutamic oxalacetic transaminase (UGOT). The UGOT was
not nearly as high as the SGOT.
Cerebrospinal Fluid
Wakim and Fleisher (1956) found normal cerebrospinal fluid
glutamic oxalacetic transaminase (CFGOT) in dogs to be approxi-
mately one-half that of their normal SGOT. Lending et al. (1959)
reported that normal human CFGOT to be from 1 to 10 units/ml/min.
and that enzymes were higher during the first 24 hours of life.
Green et al. (1957), as reported by Arst (1959), concluded that
human cerebrospinal fluid had about one-half as much GOT activity
as the corresponding serum. These authors reported the normal
human CFGOT was from 2 to 7 units. Using the Reitman-Frankel
method, Arst (1959) reported the normal human CFGOT to be between
and 39 units. This range was derived from 133 normal individ-
uals. Wakim and Fleisher (1956) found a mean level of GOT in
cerebrospinal fluid of 0.66 uM/ml/hr. in the dog.
Tissue Transaminases
The transaminases in tissues of white rats have been cali-
brated by Cohen and Hekhuis (1941). These workers found that
15
heart muscle had the largest amount of GOT, and skeletal muscle
the second largest. These were followed in order by brain, liver,
kidney, testis, lung, and spleen. These same workers reoorted
that what is now called GPT activity was much more rapid in the
liver than in other tissues examined. The work of Cornelius
et al. (1959) also indicated that GOT was greatest in heart
muscle, closely followed by skeletal muscle in most animals
studied. Their work showed a comparatively large amount of GPT
activity in the liver of the dog. The equine had a very high
GOT in the panoreas. The same tissues showed a great deal of
variation between individuals. Wroblewski et al. (1956), as re-
ported by Gurtler and Richert (1959), found that in man the GOT
activity was greatest in heart muscle followed by liver and then
skeletal muscle. The GOT level in the kidney tissue closely
approximated that of skeletal muscle. The largest amount of
GOT activity in the tissues of rats studied by Awapara and Seal
(1952) (Gurtler and Richter, 1959) was in heart muscle followed
in order of importance by skeletal muscle, kidney, brain, liver,
and testicle. Prom the reoort of Cammarata and Cohen (1950),
LaDue et al. (1954) calculated that if 1 gram of dried pig heart
was diluted to 6 liters, there would be 400 GOT units/ml. Dunn
et al. (1958) estimated the extracellular fluid pool of a dog to
contain about 30,000 units. A 2-kilogram pig heart was estimated
by Green et al. (1958) to contain approximately 750,000 GOT
units. Pleisher and Wakim (1956) reported GPT practically absent
in the brain of the normal dog.
16
The literature cited indicated that the largest amount of
GOT activity was found in the heart muscle, skeletal muscle, and
liver. Other tissues showed a much smaller activity.
Enzymatic Alteration Due to Surgery
No elevation of SGOT was found in 50 per cent of oost oper-
ative patients by Watanobe et al. (1957). Some of the post
operative patients had a slight SGOT elevation while one had a
marked increase in enzyme activity. Sickert et al. (1956) re-
ported slight elevation of SGOT as a result of surgery. Rudolph
et al. (1957) proposed that necrosis of any type of tissue would
elevate the SGOT, the degree being directly proportional to the
amount of tissue damaged.
Enzymatic Alteration Due to Heart Disease
Rudolph et al. (1957) produced experimental infarction of the
heart of dogs with resulting SGOT findings of 45 to 608 units.
LaDue et al. (1954) studied 30 patients with transmural myo-
cardial infarction. They found SGOT to be normal 3 hours after
the onset of pain. Twelve hours after onset of oain, the SGOT
level had risen to as high as 500 units. The peak levels of SGOT
were from 100 to 6000 units. In this group of patients, SGOT
returned to normal by the sixth day. Increase in transaminase
activity was reported in clinical cases of human arteriosclerotic
heart disease and recent myocardial infarction. Chinsky et al.
(1956) reported myocardial infarction caused an elevated SGOT
about 6 hours after onset of chest pain. The peak occurred 24
17
hours after the first chest pain and returned to normal level on
the third to the sixth day. Wroblewski and LaDue (1956) failed
to find much increase in SGPT as a result of myocardial infarction.
Agress et al. (1955) introduced plastic spheres into coronary
ostia of experimental dogs to artificially produce myocardial in-
farction. Electrocardiographic S-T depression was considered to
be the time of injury by the spheres. The peak rise in SGOT was
found to be 9 to 23 hours after time of injury. SGOT values 20
to 30 times normal were obtained by the procedure. Members of
the research group, separate from the ones determining the trans-
aminases, estimated the amount of infarction at autoosy in terms
of per cent of gross total heart tissue. They concluded that the
SGOT levels were directly proportional to the amount of gross
damage due to infarction. The authors thought the estimation of
amount of infarction was accurate to within 5 to 10 per cent.
Karmen et al. (1955) reported transaminase increase due to
arteriosclerotic heart disease and recent myocardial infarction.
Kattus et al. (1956) studied 5 convalescent patients with myo-
cardial infarctions and found the transaminases to be essentially
normal. The same authors reported 4 oatients with congestive
heart failure and 4 patients with acute benign pericarditis to be
within the normal range. Acute myocardial infarction was found
to give peak transaminase levels at 24 to 36 hours with a return
to normal by the fifth day after clinical onset. There was an
unexplained delay in the rise of SGOT from 6 to 12 hours after
onset.
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Steinberg and Ostrow (1955) studied 24 cases of myocardial
necrosis and found that in all but two cases the SGOT was elevated
above 40 units within 48 hours after onset of pain. Peak readings
of 54 to 308 units were recorded. These occurred 36 hours after
the first pain. They reported no significant SGOT elevations in
cases of myocardial ischemia, angina pectoris, uncomplicated
cardiac failure, and pericarditis. The increase in SGOT due to
myocardial necrosis was presumed to be a result of the release of
the enzyme from damaged heart muscle cells. Due to the rapid
rate of disappearance of the enzyme, despite its stability, the
authors postulated that there was some mechanism which removed it
from the blood. No further explanation was given.
Watanobe et al. (1957) found no SGOT elevations in cases of
mild benign idiopathic pericarditis, congestive heart failure,
aortic stenosis, healed myocarditis, mitral stenosis with atrial
flutter, subacute bacterial endocarditis, and cardiac neurosis.
Slight elevations were reported in cases of rheumatic pericarditis
and pulmonary infarction associated with congestive heart failure.
Marked elevations were found in cases of severe idiopathic
pericarditis and terminal cyanosis and collapse due to valvular
heart disease.
Fnzymatic Alterations Due to Skeletal Muscle Pathology
Skeletal muscle was found to be second to cardiac muscle in
GOT activity (Cohen and Hekhuis, 1941; Wroblewski et al., 1956;
Cornelius et al., 1959; Awapara and Seale, 1952, as reported by
Gurtler and Richter, 1959). Sickert et al. (1956) noticed
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elevated SGOT levels in cases of dermatomyositis, muscular
dystrophy, and gangrene of the toes of human patients. The SGOT
was not elevated in progressive muscular dystrophy. In contrast,
Watanobe et al. (1957) did not find SGOT elevated in dermato-
myositis. Marked elevations were reported in cases of muscular
dystrophy and paroxysmal myoglobinuria. White and Hess (1957)
studied cases of muscular dystrophy in the human and found that
SGOT levels increased. Eight children with muscular dystrophy
were found to have a SGOT mean of 2.59 uM/ml/min. as compared to
normal children with a SGOT mean of 0.85 uM/ml/min. Correspond-
ingly, 9 cases of muscular dystrophy in adults had mean SGOT
values of 0.86 uM/ml/hr. with the normal adult mean SGOT being
0.65 uM/ml/hr.
White muscle disease in calves and sheep corresponds somewhat
to muscular dystrophy in humans. Kuttler and Marble (1958) uti-
lized this similarity and studied the SGOT levels of WMD in calves
and lambs. This study utilized the naturally occurring disease
as well as cases that were artificially produced by feeding a diet
of cod liver oil and milk. In artificial cases of WMD, the first
SGOT increase was noted on the eleventh day. Clinical signs were
evident on day 23. Another case had initial elevation of SGOT on
day 21, but clinical symptoms did not appear until day 27. Two
affected lambs were treated with 600 gm. d-alpha tocopherol
acetate followed by 450 mg. the next 2 days. The animals returned
to normal clinically and the SGOT dropped in those animals that
were checked. The mean SGOT value of the 14 lambs with arti-
ficially induced WMD was 4,498 units 2,213 units. Seventeen
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field cases of WMD had a mean SGOT level of 2,574 units 2,692
units. These same researchers found that five field cases of
WMD in calves had a mean SGOT of 524 + 236 units. No significant
difference was found in SGOT of the cardiac and skeletal type of
the disease. Signs of illness usually appeared in lambs when the
SGOT level reached 2,000 units, and in calves when the SGOT level
reached 3,000 units. These authors noted that some apparently
normal animals in infected flocks of sheep had high GOT levels.
Seventeen lambs with WMD confirmed at autopsy were studied
by Blinco and Dye (1958). Lambs with WMD had SGOT range of 687 to
3,460 units. The 4 calves checked had a SGOT range of 295 to
2,360 units. These authors reported a more pronounced increase
in SGOT in lambs than in calves. It was also noted that the SGOT
level increased with the severity of the disease.
Kuttler and Marble (1959) used the same method of feeding
cod liver oil and milk to lambs to produce WMD. They recorded a
peak of 8,116 units in one lamb. Peaking of the SGOT level
occurred between 18 and 25 days after starting the animals on
this diet. Samples of blood were taken at 7 and 14 days after
feeding the same disease-producing diet to 418 lambs (Swingle
et al., 1959). It was reported that of 77 lambs with WMD, SGOT
units of over 400 units occurred in 74 lambs. They indicated that
SGOT predicted accurately the onset of WMD before clinioal signs
were manifested.
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Transaminase Activity Associated with Liver Disease
As reported earlier in the review, Cohen and Hekhuis (1941)
indicated the importance of SGPT in the liver of the rat. They
felt that there was more than one transaminating enzyme in the
liver. LaDue et al. (1954) noted high SGOT values in jaundiced
human patients with acute liver disease. Later, Karmen et al.
(1955) reported that transaminase activity was higher than normal
in acute hepatitis. Kattus et al. (1956) found that two cases of
viral hepatitis reached serum arainopherase peaks at 13 and 18
days after onset and returned to normal on the 32nd and 33rd days,
The SGPT was not appreciably elevated in diseases that did not
involve the liver (Wroblewski and LaDue, 1956). These authors
surveyed 12 human patients with viral infectious hepatitis and
found an elevated SGPT. Fifteen human patients with metastatic
oancer of the liver were studied. Five had elevated SGPT and 12
had elevated SGOT levels.
Molander et al. (1957) studied the following human diseases
and corresoonding SGOT levels: 81 patients with Laennec's cir-
rhosis, 13 to 286 units; 7 biliary cirrhosis, 57 to 330 units;
one obstructive jaundice, 320 units; 20 viral hepatitis, 540 to
1890 units; and also reported that 2 hepatitis patients of
Molander et al. (1955) had 27,840 and 12,300 units. The patients
with obstructive jaundice had a drop in SGOT following drainage
of the bile duct. Patients with viral hepatitis of 3 to 4 weeks
duration had little SGOT elevations. It was their belief that
the severest liver conditions had the highest SGOT levels.
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Watanobe et al. (1957) reported SGOT levels of 100 to 200
units in oases of biliary obstructive jaundice, but with cellular
destruction the SGOT were found in non-icteric cirrhosis of the
liver or congenital hemolytic jaundice. Slight SGOT elevation
was recorded in quiescent non-icteric cirrhosis of the liver.
Marked increase in SGOT was found in oases of viral hepatitis,
obstructive jaundice, liver cirrhosis with jaundice, and meta-
static cancer of the liver. Chinskey et al. (1956) reported that
in human jaundice, the serum bilirubin tended to follow serum
transaminase levels.
Liver damage caused by administering carbon tetrachloride to
animals (Cornelius et al.,1959) caused an elevation in SGOT of
pigs, horses, dogs, and calves. Peaks of 2800 units of SGOT and
over were recorded on day 1 in the 2 pigs studied. The dog died
but had a SGOT of 2400 units at that time. Other animals examined
did not have SGOT levels over 850 units. There was not much
change in SGPT levels in this same group of animals with the ex-
ception of the dog whose SGPT reached a peak of 2760 units on the
second day after administration of carbon tetrachloride. The
highest SGPT in other animals studied was near 100 units in the
calf at death. The other calf, one pig, and the horse continued
to have normal SGOT levels.
Compagnucci (1959) found the SGOT in ten bovine cases of
diffuse hydatidosis to be 56 to 150 units. The SGPT was reported
as being 20 to 62 units. The cases of slight hydatidosis and
tuberculosis were reported to have normal SGOT and SGPT levels.
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Transaminase Aotivity Associated with Diseases of
the Central Nervous System
Cases of neuritis, and patients with nerve seotion were re-
ported by Sickert et al. (1956) to have normal SGOT. Dogs with
carbon tetrachloride poisoning had increased CFGOT levels
(Pleisher and Wakim, 1956). They reasoned that the CPGOT increase
was due to cerebral damage as a result of the carbon tetrachloride
followed by transfer of the enzymes from the blood to the cerebro-
spinal fluid and/or hemorrhage into the spinal canal during
puncture
.
Wakim and Pleisher (1956) injected vinylacetate into the in-
ternal oarotid artery and produced cerebral infarction. The re-
sulting mean CPGOT in the 7 dogs was 5.50 uM/mi/hr. which repre-
sented an increase of 733 per cent above normal. The SGOT was
110 per oent above normal. Brain tissue examined after infarction
had a GOT value 71 per cent below normal. The authors concluded
there was no correlation between SGOT and severity of infarction
while there was a direct correlation between CPGOT and damage to
the brain.
Watanobe et al. (1957) found marked SGOT elevation associated
with infarction of the brain but none to a slight elevation in
cases of cerebral accidents. Kuttler and Marble (1958) reported
no elevation in SGOT in one lamb with staphlococcic meningitis.
The extensive study of Lending et al. (1959) of GOT in
cerebrospinal fluid and serum of normal and abnormal infants
pointed out the importance of CPGOT determination in case of brain
disease. The CPGOT range in abnormal infants was 31.6 to 855
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units. This was an increase of 82 per cent. The SGOT was ele-
vated only 18 per cent. The authors used 1 ml of cerebrospinal
fluid and followed the prooedure of Karman et al. (1955). The
authors postulated that the increase in enzyme activity in the
cerebrospinal fluid was due either to increased permeability of
the blood-cerebrospinal fluid barrier or to lysis of cerebral
cells and changes in permeability of cerebral cell membranes.
Allgen et al. (1958) followed 400 delirium tremens and allied
cases. SGOT in delirium tremens was markedly elevated. This
increase was simultaneous with mental and somatic manifestations.
The SGOT peak was found at the height of symptoms. SGOT readings
in severe cases were 200 to 1,000 units while moderate cases had
less than 300 units. As somatic and mental symptoms stopped, the
SGOT returned to normal. CPG0T was checked in a few cases and
found to be within the normal range. These authors also noted
that patients with long periods of abstinence would develop ele-
vated SGOT after one day of drinking. The SGPT was also in-
creased, but not as much as was SGOT. Severe cases of delirium
tremens had SGPT levels up to 200 units.
Arst (1959) concluded after studying 66 patients with cen-
tral nervous system disorders that CPG0T determinations had little
clinical significance. Two cases of cryptococcosis and one case
of toxoplasmosis did result in CPGOT values which were above
normal
.
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Transaminase Activity Associated with Diseases
of the Kidney
Steinberg and Ostrow (1955) found no SGOT elevation in
nephrosis with marked edema. Later, Watanobe et al. (1957) found
no significant elevation in chronic nephritis. Slight SGOT ele-
vations in probable renal infarction and marked elevation in
infarcts of the kidney were recorded by the same workers.
Fleven cases of children with a nephrotic syndrome were
studied by Stanton and Howard (1959) and found to have normal
SGOT. These workers also reported normal SGOT in acute glomerulo-
nephritis while 15 children with renal disease were found to have
below normal SGOT. Kemp (1960) studied the enzyme levels of the
arterial and venous blood of the kidney. He reported arterio-
venous differences in GOT in the kidney of normal rabbits to be
positive or zero. It was postulated this difference was due to
destruction of enzymes by the normal kidney.
Rudolph et al. (1957) found that dogs with experimental
multiple infarcts of the kidney had SGOT levels of 114 to 149
units. Nephrectomy elicited only slight elevation of the SGOT
to 58 units.
Pate of the Transaminases
Reports have substantiated the fact that there are elevations
of SGOT and SGPT in certain diseases, but very few workers have
indicated what happens to the enzymes as the level returns to
normal. Pleisher and Wakim (1956) indicated that GOT and GPT
were eliminated from tissues at the same rate. Dunn et al. (1958)
sInjected autogenous muscle extract, homologous liver, and
homologous heart lntraveneously into dogs. The serum GOT of the
dog was determined and compared with the amount in the material
injected. The SGOT dropped rapidly during the first 6 hours
after injection of material. SGOT levels returned to normal 18
to 60 hours subsequent to injection. Disappearance of GOT from
autogenous and homologous GOT extracts was similar. Strangely,
the disappearance curve of bilaterally nephrectomized dogs was
similar to the same dogs after injection of GOT containing ma-
terial indicating little or no loss of the enzyme through the
urine.
Dunn et al. (1958) found no correlation between SGOT and
the concentration and excretion of GOT in the bile, although
these workers did find that bile GOT was increased after injec-
tion of GOT material.
Other Diseases Studied for Alterations
of ^nzymatic Activity
The transaminases have been determined in various other
disease conditions. Normal SGOT levels were found in cases of
pulmonary infarction and acute pneumothorax by Steinberg and
Ostrow (1955). Wroblewski and LaDue (1956) reported that leukemia
or lymphomatous disease might alter the SGOT but not the SG^T.
In a review, Mason and Wroblewski (1957) cited literature which
stated that SGOT levels were not related to any of the following:
shock, blood pressure, anticoagulants, digitalis, quinidine, age,
sex, color, temperature, weight, sedimentation rate, white blood
cell count, or oliguria.
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In addition to the SGOT values for human diseases listed
previously by Watanobe et al. (1957), these authors found no ele-
vation of SGOT in cases of pulmonary infarction, various forms of
cancer, pneumonia, subphrenic abscess, aneurysm, and diabetes.
Karmen et al. (1955) noted increased SGOT in human lymphomatous
disease, extensive rhabdomyosarcoma, and acute leukemia.
While Kuttler and Marble (1958) were studying WMD in calves
and lambs, they also noted that 6 castrated lambs had no signifi-
cant alterations In SGOT. A lamb with photosensitization had a
SGOT of 850 units and one lamb with myiasis had a SGOT of 441
units. Blinco and Dye (1958) recorded no SGOT Increase in scours
and only a slight increase In staphlococclc meningitis in lambs.
A case with severe internal injuries had a SGOT of 82 units, while
those with toxemia had SGOT levels from 42 to 188 units. Swingle
et al. (1959) recorded a high SGOT in a lamb with suppurative
arthritis but found lambs with bronchopneumonia had normal SGOT.
One hundred thirteen pregnant women were studied by Stone
et al. (1960) during all trimesters of pregnancy, the intrapartum
period, and post partum. No elevation in SGOT was reported in any
of the patients and in many Instances the SGOT values were lower
than those of non-pregnant women.
Tonhazy et al. (1950) recorded normal SGOT in mice ill with
radiation sickness. Molander et al. (1957) reported that SGOT of
one patient with obstructive jaundice associated with Hodgkin»s
disease fell from 320 to 57 units after a T tube was placed in
the common bile duct, and later dropped to 27 units following
radiation therapy.
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Steinberg and Ostrow (1955) reported that Dr. Andrew G.
Morrow had done preliminary studies indicating that experimental
intestinal infarction in dogs could cause significant SGOT eleva-
tion
MATERIALS AND METHODS
Experimental Animals
Pour groups of dogs of mixed breeding and of both sexes were
used. The animals were from six weeks to two years of age. The
dogs were maintained in isolation and fed a commercial dry dog
food during the experiment.
The dogs in Group I were purohased in Kansas and were de-
livered on April 23, 1961. These dogs were divided into pens of
four and vaccinated with a tissue culture canine distemper
vaccine.* Upon challenge with intracerebral inoculation with
canine distemper street virus, these dogs were found to be immune.
Urine and blood were collected at varying intervals prior to
intracerebral inoculation. Cerebrospinal fluid was collected just
before intracerebral challenge.
This group was later inoculated with 1.0 ml of a 1:20 suspen-
sion of canine hepatitis virus. The deaths occurred during the
night precluding the collection of samples.
Group II consisted of dogs raised at Kansas State University
or purchased at various times from local farmers.
Jen-Sal Laboratories, Kansas City, Missouri.
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These dogs were unilaterally nephrectomized. A period of at
least four weeks later samples were collected. Later, all dogs
except control dogs were inoculated with a strain of Proteus sp.
which had been isolated from a clinical case of canine nephritis.
These dogs were then called Group V. The methods of inoculation
were as follows: (1) one-fourth ml of a 24-hour culture in
trypticase soy broth2 with 0.1 per cent agar added was inoculated
into the renal artery of the remaining kidney; (2) twenty ml of
a saline washed culture was inoculated into the renal artery of
the remaining kidney; (3) ten ml of a saline washed culture was
injected into the peripheral circulation every day for seven days.
All cultures used for inoculation were checked for viability of
the bacteria and found to be living.
Group III consisted of dogs purchased in Nebraska. The
arrival date was January 23, 1961. These dogs were vaccinated
against distemper. Shortly after arrival, these dogs developed
a diarrhea, nasal discharge, eye discharge, and some became
comatose followed by death. Chorea-like symptoms were observed
In certain dogs. When possible, samples of urine, blood, and
cerebrospinal fluid were collected prior to death.
A tentative diagnosis of canine distemper was given at
autopsy. This diagnosis was later confirmed by histopathology.
The dogs in Group IV were purchased in Arkansas and were de-
livered May 23, 1961. The dogs arrived in Manhattan apparently
healthy. Since these dogs were being utilized in other research,
Baltimore Biologic Laboratories, Baltimore, Maryland.
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controls could not be collected. These dogs were divided into
pens and handled in a manner similar to Groups I and III.
All dogs exhibiting central nervous disturbance were uti-
lized. Urine, plasma, and cerebrospinal fluid were collected
from each dog prior to euthanasia.
Collection of Plasma, Serum, Urine, and
Cerebrospinal Fluid
All blood samples were collected from the radial, saphenous,
or Jugular vein using ethylenediaminetetracetate (FDTA) as the
anticoagulant. The blood for serum samples was collected in the
same manner except no anticoagulant was used. All samples for
analysis were either serum or plasma. Only unhemolyzed samples
were utilized.
The urine was collected by catheterization or by urinary
bladder tap, using an 18 gauge 1.5 inch needle. °rior to bladder
tap, the skin was scrubbed with alcoholic Roccal.3
Cerebrospinal fluid was collected by flexing the head of the
anesthetized dog ventrally, and locating the area just dorsal to
the foramen magnum. The surface was scrubbed with alcoholic
Roccal. A sterile 20 gauge one inch needle with a sterile 5 c.c.
glass syringe attached was inserted into the foramen magnum. Two
ml of cerebrospinal fluid were aspirated. Only clear samples were
saved for testing.
The plasma, serum, urine, and cerebrospinal fluid samples
were stored at -20° C. or used the day collected. The stored
•3
Winthrop Laboratories, New York 18, New York.
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samples were allowed to warm to room temperature before being
used for transaminase determination. No samples were stored more
than two weeks
.
Transaminase Procedures
GOT Procedure * One ml of a standard solution of aspartic and
a-ketoglutarie acids 4 buffered to a pH of 7.5 was pipetted into a
15 ml test tube and placed in a water bath at 37° C. for at least
five minutes. After the initial incubation, 0,2 ml of the un-
known (plasma, serum, urine, or cerebrospinal fluid) was added
to the substrate. This was mixed and placed in a 37° C. water
bath for exactly one hour.
At the end of one hour incubation, 1 ml of a standard solu-
tion of 2,4-dinitrophenylhydrazine (DNPH) was added. This solu-
tion was mixed and allowed to stand at room temperature for 20
minutes. Ten ml of 0.4 N sodium hydroxide was added. The tube
was inverted and allowed to stand at room temperature for at least
five minutes.
This material was poured into a standard cuvette. All read-
ings for each day were made using the same cuvette. The per cent
transmittance was determined in either a Bausch and Lomb Spec-
tronic 20 colorimeter^ or a Coleman Jr. spectrophotometer. • The
instrument was adjusted to 100 per cent transmittance at a
4 All reagents for GOT and GPT were furnished by Dade
Reagents, Inc., Miami, Florida.
Bausch i Lomb Optical Company, Rochester, New York.
g Coleman Instruments, Incorporated, Maywood, Illinois.
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wavelength of 505 ray using distilled water as the reference
standard.
The number of units were read directly from a standard
curve. Under the conditions of the test, one unit was equal to
the formation of pyruvate-dinitrophenylhydrazone equivalent to
one gamma of pyruvate.
The OPT procedure was conducted in the same manner as the
GOT exceot the substrate used was a standard solution of
a-glutaric acid and alanine buffered to a pH of 7,5. The incuba-
tion time of the unknown with the substrate was 30 minutes.
Standard Control
The calibration tubes were set up as indicated in Table 2.
Table 2. Procedure for establishing calibration curve.
Cuvette "T~ :Standard : Calibration: SGOT : SGPT
No. : Water :substrate : standard : Units/ml : Units/ml
1 0.2 ml 1,0 ml 0.0 ml
2 0.2 ml 0.9 ml 0.1 ml 22 25
3 0.2 ml 0.8 ml 0,2 ml 55 50
4 0.2 ml 0.7 ml 0.3 ml 95 83
5 0.2 ml 0.6 ml 0.4 ml 150 126
6 0.2 ml 0.5 ml 0.5 ml 215
One ml of DNPH was added to each of the above tubes and
allowed to stand at room temperature for twenty minutes. Ten ml
of 0.4N sodium hydroxide was added to each tube. The tubes were
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inverted and allowed to stand at room temperature for at least
five minutes. The readings were made as described in the GOT
and GPT procedure. Calibration readings were plotted on single
cycle semi-logarithmic paper with 84 divisors.
All reagents were of the same lot number. As each group of
unknowns was tested, two control tubes were prepared. These con-
trols were at levels representing 22 units of GOT and 25 units of
GPT in one tube and 95 units of GOT and 83 units of GPT in the
other tube. All points of the calibration curve were checked at
periodic intervals. Standard curves were preoared for both the
Bausch and Lomb Spectronic 20 and the Coleman Jr. spectropho-
tometers .
During the early part of this study 0.2 ml of urine was
added to the reference blank and used in the procedure. This was
done to check the effect that the urine pigments had on the per
cent transmittance at this wavelength. This did not prove to be
a significant factor, so the procedure was discontinued.
RESULTS AND DISCUSSION
Serum Glutamic Oxalacetic Transaminase
The SGOT findings are summarized in Table 3.
The normal range was considered to be the mean plus or minus
the standard deviation. Therefore, the normal SGOT range for the
dogs studied was found to be 17 to 36.2 units in group I and 18.7
to 41.7 units in group II. Any dogs having a SGOT between 17 and
41.7 units were considered to be within the normal range.
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Table 3. Summary of serum glutamic oxalacetic transaminase
(SGOT).
1 Mean SGOT in units
Standard error in units
Standard deviation in units
4 Central nervous symptoms
: No. 1 : Range
Group No. :
No.
dogs
: determi-:
: nations :
_1
X ; s"
: 3
8
: in
: units
I Normal 15 38 26.6 1.555 9.58 12-55
II Normal 28 103 30.18 1.129 11.50 4-66
III Distemper
IV CNS4
7 7 38.9 8.610 22.74 12-62
11 11 78.0 23.10 61.00 22-162
V Nephritis 15 96 29.0 5.477 13.62 8-160
Using the confidence interval, there was a statistically
significant difference between these two groups. However, there
was also a difference between the results of the studies of Ray
(1958) and Cornelius et al. (1959) using this same method of
analysis (Table 1). Both of these workers used the same method
of enzymatic determination. The normal mean SGOT found in this
research was higher than the above authors,, but lower than that
of Lemley-Stone (1958) (Table 1).
The SGOT dog-to-dog variation In groups I and II was 9.58
units and 11.5 units, respectively. Therefore, the mean differ-
ence between the two groups was considered to be relatively
normal for this method of determination.
Mason and Wroblewski (1957) reported a transient SGOT eleva-
tion one to four days following surgery. Collection of samples
from all dogs in group II was not instituted for at least one
month following nephrectomy. Therefore, this probably was not a
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factor In the group II dogs.
Standard errors of these two groups of normal dogs were found
to be small. This indicated the accuracy of this method of test.
In group III, all of the data indicated that the SGOT deter-
mination was not a reliable diagnostic aid in the detection of
canine distemper. The mean SGOT was 38.9 units with a range of
16.2 to 61.6 units. This range was considered to be too near the
normal to be of diagnostic value. Three of the seven dogs in
this group had SGOT readings of 62 units. The other four dogs
had 30 SGOT units or less.
There was a significant mean SGOT increase in the dogs with
central nervous system involvement. However, the SGOT level of
six of these dogs was within the normal range. The SGOT eleva-
tion of the other five dogs may have been due to one or more of
the following: (1) cellular death during the course of the
disease, (2) cellular destruction associated with impending death
regardless of the cause, (3) accumulation of the enzymes due to
reduced metabolic activity just prior to death. The standard
error and standard deviation were extremely large in this grouD.
Although the SGOT range in group IV was wide, the mean SGOT
was well within the normal. There did not seem to be a specific
pattern in the SGOT of these dogs. Although there was generally
a transient rise in SGOT for from one to three days in most of the
dogs following the surgical procedure of inoculation, only two
dogs of this group had SGOT above 66 units during this experiment
(Table 4). One of these had an SGOT of 86 units the day following
inoculation into the renal artery. This may have been due to the
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Table 4. Transaminases of two nephritic dogs.
Date : SGOT : SGPT : UGOT : UGPT
Dor #18H
12-31-60 unilateral nephrectomy
2- 8-61 39 42 31 24
4-13-61 33 42 62 46
4-22-61 24 27 25 26
4-22-61 inoculated with 20 ml Proteus sp. via renal artery
4-23-61 54 44 14 16
4-24-61 38 32 20 21
4-25-61 160 55 30 21
4-26-61 86 32 16 4
4-28-61 62 29 26 34
4-29-61 34 16 — —
5-16-61 46 38 20 26
5-17-61 34 24 9
5-24-61 20 22 --
6-22-61 24 31 27 32
Doff #17H
12-31-60 unilateral nephrectomy
2- 8-61 26 38 22 22
4-11-61 20 26 42 28
4-12-61 4 29 8 30
5- 3-61 M 24 24
5- 6-61 a.m. inoculated with 20 ml Proteus sp. via renal artery
5- 6-61 p.m. 86 38 42 34
5- 7-61 34 29 26 26
5- 8-61 38 34 30 34
5-10-61 26 26 38 40
surgery involved. The other dog (18H) had an SGOT of 160 units
the third day subsequent to inoculation into the renal artery.
The following day the SGOT had dropped to 86 units and had re-
turned to a normal of 34 units by the sixth day following inocula-
tion. This information indicated the limitation of the SGOT for
the detection of this type of nephritis. This also demonstrated
the day-to-day variation of the SGOT during the course of disease,
The above information emphasized that the clinician or research
worker should not rely upon a single determination.
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Serum Glutamic Pyruvic Transaminase
The SGPT findings are summarized in Table 5.
Table 5. Summary of serum glutamic pyruvic transaminase (SGPT).
: No. : : Range
No. rdetermi-: 1 : . 2 : 3 : in
Group No. : dogs rnations : X : »x : s : units
I Normal 15 38 24.0 1.657 10.21 6-42
II Normal 28 103 29.9 1,021 10.41 12-55
III Distemper 7 7 21.7 10.68 28.21 2-83
IV CNS* 11 11 36.6 6.77 17.87 22-82
V Nephritis 14 103 29.4 4.08 9.49 8-68
Mean in units
2 Standard error In units
Standard deviation in units
4 Central nervous symptoms
The SGPT of the two normal groups had essentially the same
relationship as did the SGOT. The normal range was considered
to be 13.8 to 34.2 units for group I and 19.5 to 40.3 units were
considered to be within the normal range. The ranges of these
two groups of dogs were nearly alike. Again, the standard error
was small and the standard deviation was slightly larger than ten
units. Normal mean SGPT was higher than had been reported by Ray
(1958) and Cornelius et al. (1959) (Table 1). The slightly dif-
ferent enzymatic test used in this study may account for this
difference.
The results of SGPT in dogs with natural distemper infection
(group III) indicated that this test had little value as a diag-
nostic aid. The standard error and the standard deviation were
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large. The sizable standard error indicated that there was con-
siderable variability within each dog while the large standard
deviation denoted that there was considerable dog-to-dog vari-
ation. All but one dog of this group were within the normal SGPT
range
.
Dogs with central nervous system disturbances had SGPT find-
ings essentially the same as group III. Four of the 11 dogs of
this group had SGPT readings above the normal range.
SGPT findings in dogs with nephritis were considered to be
within the normal range. There were some border line elevations,
but they were not considered to be of value as an aid to diagnosis
of this type of nephritis.
Urine Glutamic Oxalacetic Transaminase
The UGOT findings are summarized in Table 6.
Table 6. Summary of urine glutamic oxalacetic transaminase
(UGOT).
-
: No. : : Range
No. tdetermi-: 1 : s 2 1 3
s
in
Group No. : dogs mations : X : x : : units
I Normal 16 46 26.0 1.743 11.82 4-55
II Normal 28 78 20.4 1.551 13.70 0-58
III Distemper 6 6 54.6 35.637 87.29 6-232
IV CNS4 10 10 47.1 12.055 38.12 20-150
V Nephritis 14 81 25.2 7.432 13.80 3-83
Mean in units
Standard error in units
Standard deviation in units
Central nervous symptoms
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The results of this work were contrary to the findings of
Dunn et al. (1958) who found little or no transaminase activity in
the urine of dogs, ^very dog had significant transaminase levels
in the urine at some time. The mean UGOT of group I was higher
than that of group II. The normal range of UGOT of group I was
14.2 to 37.8 units and 6.7 to 34.1 units In group II.
Group III dogs did have a significantly elevated mean UGOT;
however, only one dog of this group was above the normal range.
This was also the case in group IV.
The mean UGOT of group V was considered normal.
Urine Glutamic Pyruvic Transaminase
Results of urine glutamic pyruvic transaminase (UGPT) find-
ings are summarized in Table 7.
Table 7. Summary of urine glutamic pyruvic transaminase (UGPT).
: No. : : : : Range
No. : determi-»: 1 1 mJ* t 5 : in
Group No. : dogs nations : X x : 8 : units
I Normal 16 46 27.2 1.114 8.55 0-50
II Normal 26 78 21.7 1.176 10.58 0-50
III Distemper
IV CNS4
6 6 28.5 4.072 9.97 12-39
10 10 29.8 3.498 11.06 16-54
V Nephritis 14 80 25.0 4.779 8.70 7-40
2
Mean in units
Standard error in units
Standard deviation in units
Central nervous symptoms
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The normal UGPT range was from 11,2 to 35.7 units.
All dogs in the other groups had UGPT readings that were con-
sidered to be essentially normal. The standard error was much
larger in groups III, IV, and V. This indicated that there was a
greater variability within the diseased dogs of the latter groups
than there was within the normal dogs of groups I and II. The
dog-to-dog variability remained relatively constant In all groups.
Cerebrospinal Fluid Glutamic Oxalacetic Transaminase
The findings of cerebrospinal fluid glutamic oxalacetic
transaminase (CFGOT) are summarized in Table 8.
Table 8. Summary of cerebrospinal fluid glutamic oxalacetic
transaminase (CFGOT).
Group No.
No.
dogs
: No.
: determi-
nations s_<X
Range
in
units
I and II4
Normal 43
III Distemper 8
IV CNS5 14
43
8
14
20.0
41.8
81.5
1.62
18.004
18.245
10.62
50.92
68.24
6-46
4-150
20-260+
Mean in units
Standard error in units
Standard deviation in units
Groups I and II were combined in this analysis
Central nervous symptoms
The normal range of the CFGOT was from 9.4 to 30.6 units in
these 43 dogs. The mean CFGOT was found to be approximately two-
thirds the normal SG0T. This difference between normal CFGOT and
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SOOT was not as great as the 50 per cent reported by Wakim and
Pleisher (1956). The necessity for general anesthesia for col-
lection of specimens limited the number of samples in the cerebro-
spinal fluid studies.
In group III the mean CPGOT was significantly higher than
the normal. Three of the eight dogs had CPGOT readings of 150,
86, and 36 units. All others of this group were within the
normal range. The extreme dog-to-dog variation was indicated by
the large standard error of 50.92 units. This indicated that this
test would be of limited value as an aid to the diagnosis of
canine distemper.
Eleven of the 14 dogs in group IV had CPGOT readings above
the normal range. This CPGOT elevation was probably related to
the amount of cellular destruction of nervous tissue. These
findings pointed out the possibility of using this test as an aid
in the detection of central nervous system diseases. The limita-
tions of this test were indicated by the large standard error and
standard deviation.
Cerebrospinal Fluid Glutamic Pyruvic Transaminase
The cerebrospinal fluid glutamic pyruvic transaminase
(CPGPT) results are summarized in Table 9.
The normal range of CPGPT was 7.5 to 21.1 units. The mean
CPGPT was 6.6 units smaller than the corresponding CPGOT. This
was the same general relationship that was found between the
normal mean SGOT and SGPT.
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Table 9. Summary of cerebrospinal fluid glutamic pyruvic trans-
aminase (CPGPT).
Group No.
No.
dogs
: No.
tdetermi-
: nations »x
2
Range
in
units
I and II4
Normal 43
III Distemper 8
IV CNS 5 14
43
8
14
13.4
15.5
30.7
1.173
4.127
2.492
7.697
11.674
9.326
2-32
0-33
14-44
Mean in units
Standard error in units
Standard deviation in units
Groups I and II were combined for this analysis
Central nervous symptoms
There was only a slight difference in the CFGPT of group III
and the normal. Only two dogs had CPGPT readings above the normal
range with readings of 33 and 26 units.
As was the case with CFGOT, the CPGPT seemed to be generally
elevated in group IV. Eleven of the 14 dogs in this group also
had enzymatic elevations. However, these were not necessarily
the same 11 dogs of this group that exhibited CPGOT elevations
(Table 10).
By using a combination of the two (CPGOT and CPGPT), all
dogs of this group except number 37 had either an elevated CPGOT
or an elevated CPGPT, or both. This strongly Indicated the need
for utilizing both enzymatic determinations to study central
nervous system diseases.
In considering the overall transaminase relationship, it was
notioed that the spread between the mean SGOT and UGOT of group I
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Table 10. Transaminase of dogs in group IV.
•
• Units
Dog No. : SGOT : SGPT : UG0T : UGPT : CPG0T :
160
CPGPT
6 70 32 26 24 40
13 162 32 54 34 mm
20 150 38 -- — 162 24
24 138 50 54 40 >260 44
30 ~ m -- -- mm 95 32
31 34 18 20 19 30 24
33 «•« mmt -- .- 38 21
34 -- _•» 26 26 42 26
35 26 24 23 16 55 34
36 -- *»a» 38 32 M ot«*
37 30 26 38 29 20 14
41 162 45 .. — — 70 32
42 30 34 — m» -- 86 21
44 34 22 42 24 55 44
48 -- MMV 150 54 30 34
49 22 82 ~— -- 39 40
dogs was only 0.6 unit. The spread between the mean SGOT and
UG0T of group II was 9.7 units. The same general relationship
occurred in the case of SGPT and UGPT. No explanation could be
given for this peculiar analogy. A speculative cause may have
been the unilateral nephrectomy of the group II dogs
.
There have been many different methods of determination de-
vised (Karmen et al., 1955; Karmen, 1955; Tonhazy, 1950; Cabaud
et al., 1956; Steinberg et al., 1956; Reitman and Frankel, 1957;
Bowers et al., 1958; and King, 1958). After reviewing the liter-
ature and completion of this study, it was felt that a standard
procedure should be adopted by the clinical pathology laboratories
for determining the transaminases. Then a research worker could
more accurately compare his results with those of another. The
clinician could more accurately utilize the results of the
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transaminase test. This was in agreement with Daly and Jordan
(1959).
SUMMARY AND CONCLUSIONS
The normal mean SGOT was 26.6 units in group I dogs and
30.18 in group II dogs. The normal range SGOT was 17 to 36.2
units. The respective mean SGPT value of these two groups of
dogs was 24.0 and 29.9 units. The normal range of SGPT for these
dogs was 13.8 to 40,3 units. Dogs in these groups were considered
to be normal.
The normal mean UGOT levels of groups I and II were 26.0 and
20.4 units, respectively. The normal range was from 6.7 to 34.1
units. These same groups of dogs had a normal UGPT range of
11.2 to 35.7 units. The mean UGPT for group I was 27.2 and the
mean for group II and 21.7.
Normal mean CPG0T was 20 units with a normal range of 9.4 to
30.6 units. The normal CPGPT mean was 13.4 units with a normal
range of 7.5 to 21.1 units.
Less spread was noticed between the SGOT and UGOT of dogs in
grout) I than those of group II. Unilateral nephrectomy of the
dogs in group II may have had some relationship to this phe-
nomenon.
The transaminase tests were not significantly altered in the
dogs with natural distemper infection. The transaminases of the
dogs with experimental nephritis were not significantly altered
although a transient rise was noticed in some of the dogs follow-
ing the surgery associated with inoculation.
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The CPGOT and/or CFGPT was elevated In 13 of the 14 dogs
with central nervous system disturbance. This alteration was
more consistent than transaminase from the urine or blood.
The standard error and standard deviation were generally
greater in the diseased dogs than in the normal dogs. The adop-
tion of a standardized transaminase procedure was recommended.
The need for a series of determinations from a patient was indi-
cated from these studies.
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Transaminases have been used extensively in diagnostic and
research work in the field of human medicine. This clinical
pathological aid has more recently become prominent in the field
of small animal veterinary medicine. Spectrophotometric trans-
aminase analysis with prepared reagents has come into use while
most of the normal enzymatic ranges were established by a slightly
altered method. The transaminases in normal canine urine and
cerebrospinal fluid has had limited study. The need for estab-
lishing the normal range of SGOT, SGPT, UGOT, UGPT, CPGOT, and
CPGPT using prepared reagents was apparent. There was also a
need of establishing the day-to-day variation of normal dogs
and animal-to-animal variation of normal dogs. These normal
variations can then be applied to diseased animals. T^ach normal
urine transaminase was derived from 124 samples, and each normal
serum transaminase was derived from 141 samples. The normal
range SGOT was 17 to 36.2 units; the normal range SGPT was 13.8
to 40.3 units. The normal range UGOT was 6.7 to 34.1 units, and
the normal range UGPT was 11.2 to 35.7 units.
There was a greater difference between SGOT and UGOT of
normal dogs that had previously been unilaterally neohrectomized
than the other group of normal dogs . Removal of one kidney may
have had some bearing upon this difference.
One cerebrospinal fluid specimen was collected from each of
43 dogs. The normal range CFGOT was 9.4 to 30.6 units and the
normal range CPGPT was 7.5 to 21.1 units.
Three groups of abnormal dogs were studied. One group of
diseased dogs consisted of dogs Inoculated intravenously with
2Proteus sp. The dogs were inoculated by one of the following
methods: (1) washed saline suspension of the organism via renal
artery, (2) washed saline suspension of the organism via peri-
pheral vein, or (3) 0.25 ml of Proteus so. culture in tryptocase
soy broth with 0.1 per cent agar added via the renal artery.
A transient elevation did occur as a result of surgery per-
formed in the process of inoculating the dogs via the renal
artery. The nephritis produced did not result in a significant
elevation of the transaminases in urine or blood.
Terminal specimens of blood urine and cerebrospinal fluid
were collected from seven dogs with a natural infection of canine
distemper. The transaminases were not consistently significantly
altered.
Sixteen dogs that had been inoculated intracerebrally with a
canine distemper street virus and developed central nervous
symptoms were studied.
Blood, urine, and cerebrospinal fluid was collected prior to
euthenasia, and the amount of transaminase in the specimens was
determined. The SGOT and SGPT were slightly elevated in 3 dogs.
The CFGOT and/or CFGPT was elevated in 13 of the 14 cerebrospinal
fluid samples utilized. The urine transaminase changes were not
significant.
The standard error and standard deviation were greater in
diseased dogs than in normal dogs. This study indicated the need
for the study of a series of specimens rather than one single
specimen. The adoption of a standard procedure for determining
transaminases was recommended.
